Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition

• Lorena Martin-Morales ,

  Contributed equally to this work with: Lorena Martin-Morales, Paula Rofes

  Roles Formal analysis, Writing – review & editing

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  ⨯
• Paula Rofes ,

  Contributed equally to this work with: Lorena Martin-Morales, Paula Rofes

  Roles Formal analysis, Investigation

  Affiliation Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain

  ⨯
• Eduardo Diaz-Rubio,

  Roles Supervision

  Affiliations CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain, Medical Oncology, Hospital Clinico San Carlos, Madrid, Spain

  ⨯
• Patricia Llovet,

  Roles Supervision

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  ⨯
• Victor Lorca,

  Roles Formal analysis

  Affiliation Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain

  ⨯
• Inmaculada Bando,

  Roles Methodology

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  ⨯
• Pedro Perez-Segura,

  Roles Formal analysis

  Affiliation Medical Oncology, Hospital Clinico San Carlos, Madrid, Spain

  ⨯
• Miguel de la Hoya,

  Roles Writing – review & editing

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  ⨯
• Pilar Garre,

  Roles Supervision

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  http://orcid.org/0000-0001-8285-4138

  ⨯
• Vanesa Garcia-Barberan,

  Roles Writing – review & editing

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  ⨯
• Trinidad Caldes

  Roles Conceptualization, Funding acquisition, Writing – original draft, Writing – review & editing

  * E-mail: trinidad.caldes@salud.madrid.org

  Affiliations Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, Madrid, Spain, CIBERONC (Centro de Investigacion Biomedica en Red de Cancer), Carlos III Health Institute, Madrid, Spain

  http://orcid.org/0000-0002-1038-5392

  ⨯